CS200517B2 - Process for preparing derivatives of androstan-17-one or androsten-17-one - Google Patents

Process for preparing derivatives of androstan-17-one or androsten-17-one Download PDF

Info

Publication number
CS200517B2
CS200517B2 CS774682A CS468277A CS200517B2 CS 200517 B2 CS200517 B2 CS 200517B2 CS 774682 A CS774682 A CS 774682A CS 468277 A CS468277 A CS 468277A CS 200517 B2 CS200517 B2 CS 200517B2
Authority
CS
Czechoslovakia
Prior art keywords
sterol
derivatives
culture
hydrogen atom
androsten
Prior art date
Application number
CS774682A
Other languages
Czech (cs)
English (en)
Inventor
Alfred Weber
Mario Kennecke
Helmut Dahl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to CS785917A priority Critical patent/CS200518B2/cs
Priority to CS785919A priority patent/CS200520B2/cs
Priority to CS785918A priority patent/CS200519B2/cs
Publication of CS200517B2 publication Critical patent/CS200517B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS774682A 1976-07-16 1977-07-13 Process for preparing derivatives of androstan-17-one or androsten-17-one CS200517B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CS785917A CS200518B2 (cs) 1976-07-16 1978-09-13 Způsob výroby androslanových derivátů
CS785919A CS200520B2 (cs) 1976-07-16 1978-09-13 Způsob výroby androstan-17-onových derivátů
CS785918A CS200519B2 (cs) 1976-07-16 1978-09-13 Způsob výroby androstanových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
CS200517B2 true CS200517B2 (en) 1980-09-15

Family

ID=5983514

Family Applications (1)

Application Number Title Priority Date Filing Date
CS774682A CS200517B2 (en) 1976-07-16 1977-07-13 Process for preparing derivatives of androstan-17-one or androsten-17-one

Country Status (18)

Country Link
US (1) US4179336A (da)
JP (1) JPS5315493A (da)
AT (1) AT363196B (da)
BE (1) BE856860A (da)
CH (3) CH627190A5 (da)
CS (1) CS200517B2 (da)
DD (4) DD132439A5 (da)
DE (1) DE2632677A1 (da)
DK (1) DK142372C (da)
FR (4) FR2365588A1 (da)
GB (1) GB1585786A (da)
HU (4) HU179344B (da)
IE (1) IE45304B1 (da)
IT (1) IT1077339B (da)
NL (1) NL7706638A (da)
SE (1) SE440779B (da)
SU (1) SU980628A3 (da)
YU (1) YU164277A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (da) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Catalytic Chem Ind Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
CA2510040C (en) * 2003-05-23 2012-01-03 Nektar Therapeutics Al, Corporation Polymeric reagents and polymer-biomolecule conjugates comprising carbamate linkages
WO2011053048A2 (ko) * 2009-10-29 2011-05-05 연세대학교 산학협력단 신규 혈관누출 차단제
WO2012116290A2 (en) 2011-02-25 2012-08-30 Washington University Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
ES2738526T3 (es) 2011-10-14 2020-01-23 Sage Therapeutics Inc Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos
RU2663665C2 (ru) 2012-12-18 2018-08-08 Вашингтон Юниверсити Нейроактивные 19-алкокси-17-замещенные стероиды и способы лечения с их применением
US10202413B2 (en) 2013-02-15 2019-02-12 Washington University Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
CA2909546C (en) 2013-04-17 2019-01-22 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
SG11201508550XA (en) 2013-04-17 2015-11-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
EP3035940B1 (en) 2013-08-23 2018-10-17 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PL3206493T3 (pl) 2014-10-16 2021-01-25 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
SG10202009861SA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
LT3224269T (lt) 2014-11-27 2020-07-10 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
PL3250210T3 (pl) 2015-01-26 2021-07-26 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
CN116162121A (zh) 2016-07-11 2023-05-26 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
MX2021014515A (es) 2019-05-31 2022-03-22 Sage Therapeutics Inc Esteroides neuroactivos y composiciones de estos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (da) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
CH627190A5 (da) 1981-12-31
GB1585786A (en) 1981-03-11
DE2632677C2 (da) 1988-06-16
SE440779B (sv) 1985-08-19
IE45304B1 (en) 1982-07-28
DK323677A (da) 1978-01-17
FR2372175A1 (fr) 1978-06-23
DD132439A5 (de) 1978-09-27
JPS6117477B2 (da) 1986-05-07
ATA504677A (de) 1980-12-15
DK142372C (da) 1981-03-23
DK142372B (da) 1980-10-20
SE7708192L (sv) 1978-01-17
HU182681B (en) 1984-02-28
FR2365588B1 (da) 1982-06-25
DD136142A5 (de) 1979-06-20
JPS5315493A (en) 1978-02-13
DE2632677A1 (de) 1978-01-26
DD137235A5 (de) 1979-08-22
FR2372176A1 (fr) 1978-06-23
FR2365588A1 (fr) 1978-04-21
AT363196B (de) 1981-07-10
BE856860A (fr) 1978-01-16
HU182790B (en) 1984-03-28
HU182789B (en) 1984-03-28
SU980628A3 (ru) 1982-12-07
US4179336A (en) 1979-12-18
IE45304L (en) 1978-01-16
CH629222A5 (de) 1982-04-15
FR2372174A1 (fr) 1978-06-23
DD136141A5 (de) 1979-06-20
YU164277A (en) 1982-08-31
IT1077339B (it) 1985-05-04
NL7706638A (nl) 1978-01-18
HU179344B (en) 1982-10-28
CH629503A5 (de) 1982-04-30

Similar Documents

Publication Publication Date Title
CS200517B2 (en) Process for preparing derivatives of androstan-17-one or androsten-17-one
US4230625A (en) Process for chenodeoxycholic acid and intermediates therefore
US4100027A (en) Process for the preparation of 4-androstene-3,17-dione derivatives
US4301246A (en) Process for chenodeoxycholic acid production
CS205010B2 (en) Method of producing 7-hydroxy estradiols
US20040220158A1 (en) 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
US4170518A (en) Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use
CS258482B2 (en) Method of 4-androstane-3,17-dione and 1,4-androstadiene-3,17-dione production
CS200519B2 (cs) Způsob výroby androstanových derivátů
US4100026A (en) Process for the preparation of 4-androstene-3,17-dione derivatives
US4097334A (en) Process for the preparation of androstane-3,17-dione derivatives
US3379621A (en) Microbiological preparation of delta1, 3, 5(10)-3-hydroxy steroids
US3344156A (en) Process for the preparation of equilin and intermediate obtained therefrom
RU2082762C1 (ru) Способ получения 17-оксостероидов
JPH0460480B2 (da)
US20060100185A1 (en) 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
DK146007B (da) Analogifremgangsmaade til fremstilling af d-homosteroider
JPH02360B2 (da)
Weber et al. Preparation of 3-oxo-Δ 1, 4-steroids